Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWTobramycin is an aminoglycoside antibiotic.1 It binds to the 30S ribosomal subunit, inhibiting protein synthesis. Tobramycin is active against a variety of Gram-positive and Gram-negative bacteria, including several strains of S. aureus, P. aeruginosa, E. coli, K. pneumoniae, and Enterobacter (mean MICs = 0.2, 0.6, 1.2, 0.8, and 0.8 µg/ml, respectively). It reduces the number of colony-forming units (CFUs) in several mouse models of thigh infection.2 Formulations containing tobramycin have been used in the treatment of Gram-positive and Gram-negative bacterial infections.
WARNING This product is not for human or veterinary use.
1. Tobramycin: An overview. J. Infect. Dis. 134(Suppl. 1), S3-S19 (1976).
2. Correlation between in vitro and in vivo activity of antimicrobial agents against gram-